Logo image of CARM.PA

CARMILA (CARM.PA) Stock Fundamental Analysis

EPA:CARM - Euronext Paris - Matif - FR0010828137 - REIT - Currency: EUR

17.24  +0.16 (+0.94%)

Fundamental Rating

6

CARM gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 43 industry peers in the Diversified REITs industry. While CARM belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. CARM scores decently on growth, while it is valued quite cheap. This could make an interesting combination. These ratings would make CARM suitable for value investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

CARM had positive earnings in the past year.
In the past year CARM had a positive cash flow from operations.
CARM had positive earnings in 4 of the past 5 years.
Each year in the past 5 years CARM had a positive operating cash flow.
CARM.PA Yearly Net Income VS EBIT VS OCF VS FCFCARM.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

1.2 Ratios

The Return On Assets of CARM (4.65%) is better than 79.07% of its industry peers.
CARM has a Return On Equity of 9.19%. This is amongst the best in the industry. CARM outperforms 81.40% of its industry peers.
CARM has a Return On Invested Capital of 4.52%. This is in the better half of the industry: CARM outperforms 69.77% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CARM is in line with the industry average of 4.02%.
The 3 year average ROIC (3.52%) for CARM is below the current ROIC(4.52%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.65%
ROE 9.19%
ROIC 4.52%
ROA(3y)2.69%
ROA(5y)1.6%
ROE(3y)5.18%
ROE(5y)3.03%
ROIC(3y)3.52%
ROIC(5y)3.08%
CARM.PA Yearly ROA, ROE, ROICCARM.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

1.3 Margins

CARM has a better Profit Margin (61.91%) than 76.74% of its industry peers.
In the last couple of years the Profit Margin of CARM has grown nicely.
CARM has a Operating Margin of 89.71%. This is amongst the best in the industry. CARM outperforms 88.37% of its industry peers.
CARM's Operating Margin has improved in the last couple of years.
CARM has a Gross Margin of 73.12%. This is comparable to the rest of the industry: CARM outperforms 51.16% of its industry peers.
In the last couple of years the Gross Margin of CARM has remained more or less at the same level.
Industry RankSector Rank
OM 89.71%
PM (TTM) 61.91%
GM 73.12%
OM growth 3Y17.79%
OM growth 5Y7.19%
PM growth 3Y11.44%
PM growth 5Y20.21%
GM growth 3Y2.7%
GM growth 5Y-0.75%
CARM.PA Yearly Profit, Operating, Gross MarginsCARM.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 100 150 200

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CARM is destroying value.
Compared to 1 year ago, CARM has less shares outstanding
Compared to 5 years ago, CARM has more shares outstanding
The debt/assets ratio for CARM has been reduced compared to a year ago.
CARM.PA Yearly Shares OutstandingCARM.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
CARM.PA Yearly Total Debt VS Total AssetsCARM.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

Based on the Altman-Z score of 0.97, we must say that CARM is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.97, CARM is in the better half of the industry, outperforming 62.79% of the companies in the same industry.
CARM has a debt to FCF ratio of 9.40. This is a negative value and a sign of low solvency as CARM would need 9.40 years to pay back of all of its debts.
CARM has a Debt to FCF ratio of 9.40. This is amongst the best in the industry. CARM outperforms 83.72% of its industry peers.
CARM has a Debt/Equity ratio of 0.78. This is a neutral value indicating CARM is somewhat dependend on debt financing.
The Debt to Equity ratio of CARM (0.78) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF 9.4
Altman-Z 0.97
ROIC/WACC0.89
WACC5.09%
CARM.PA Yearly LT Debt VS Equity VS FCFCARM.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

CARM has a Current Ratio of 1.22. This is a normal value and indicates that CARM is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.22, CARM is in the better half of the industry, outperforming 79.07% of the companies in the same industry.
A Quick Ratio of 1.22 indicates that CARM should not have too much problems paying its short term obligations.
CARM has a better Quick ratio (1.22) than 83.72% of its industry peers.
Industry RankSector Rank
Current Ratio 1.22
Quick Ratio 1.22
CARM.PA Yearly Current Assets VS Current LiabilitesCARM.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 15358.74% over the past year.
The Earnings Per Share has been growing by 22.86% on average over the past years. This is a very strong growth
CARM shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.72%.
The Revenue has been growing slightly by 2.93% on average over the past years.
EPS 1Y (TTM)15358.74%
EPS 3Y18.46%
EPS 5Y22.86%
EPS Q2Q%815.55%
Revenue 1Y (TTM)9.72%
Revenue growth 3Y5.68%
Revenue growth 5Y2.93%
Sales Q2Q%19.15%

3.2 Future

The Earnings Per Share is expected to grow by 4.49% on average over the next years.
The Revenue is expected to grow by 3.14% on average over the next years.
EPS Next Y6.37%
EPS Next 2Y5.14%
EPS Next 3Y4.49%
EPS Next 5YN/A
Revenue Next Year11.76%
Revenue Next 2Y4.63%
Revenue Next 3Y3.14%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CARM.PA Yearly Revenue VS EstimatesCARM.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 100M 200M 300M 400M 500M
CARM.PA Yearly EPS VS EstimatesCARM.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0.5 1 1.5

8

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 7.80 indicates a rather cheap valuation of CARM.
CARM's Price/Earnings ratio is rather cheap when compared to the industry. CARM is cheaper than 81.40% of the companies in the same industry.
CARM's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 29.35.
A Price/Forward Earnings ratio of 9.62 indicates a reasonable valuation of CARM.
65.12% of the companies in the same industry are more expensive than CARM, based on the Price/Forward Earnings ratio.
CARM's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.10.
Industry RankSector Rank
PE 7.8
Fwd PE 9.62
CARM.PA Price Earnings VS Forward Price EarningsCARM.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

81.40% of the companies in the same industry are more expensive than CARM, based on the Enterprise Value to EBITDA ratio.
81.40% of the companies in the same industry are more expensive than CARM, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 8.32
EV/EBITDA 10.99
CARM.PA Per share dataCARM.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of CARM may justify a higher PE ratio.
PEG (NY)1.22
PEG (5Y)0.34
EPS Next 2Y5.14%
EPS Next 3Y4.49%

6

5. Dividend

5.1 Amount

CARM has a Yearly Dividend Yield of 7.32%, which is a nice return.
CARM's Dividend Yield is a higher than the industry average which is at 8.60.
Compared to an average S&P500 Dividend Yield of 2.33, CARM pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.32%

5.2 History

The dividend of CARM decreases each year by -4.29%.
Dividend Growth(5Y)-4.29%
Div Incr Years0
Div Non Decr Years0
CARM.PA Yearly Dividends per shareCARM.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2024 0.2 0.4 0.6 0.8

5.3 Sustainability

54.49% of the earnings are spent on dividend by CARM. This is a bit on the high side, but may be sustainable.
DP54.49%
EPS Next 2Y5.14%
EPS Next 3Y4.49%
CARM.PA Yearly Income VS Free CF VS DividendCARM.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M
CARM.PA Dividend Payout.CARM.PA Dividend Payout, showing the Payout Ratio.CARM.PA Dividend Payout.PayoutRetained Earnings

CARMILA

EPA:CARM (3/7/2025, 7:00:00 PM)

17.24

+0.16 (+0.94%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-11 2025-02-11/amc
Earnings (Next)04-17 2025-04-17
Inst Owners31.45%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap2.44B
Analysts81.33
Price Target20.75 (20.36%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 7.32%
Yearly Dividend1.21
Dividend Growth(5Y)-4.29%
DP54.49%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.8%
PT rev (3m)7.9%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.12%
EPS NY rev (3m)-0.84%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)1.75%
Revenue NY rev (3m)1.86%
Valuation
Industry RankSector Rank
PE 7.8
Fwd PE 9.62
P/S 4.82
P/FCF 8.32
P/OCF 8.24
P/B 0.72
P/tB 0.72
EV/EBITDA 10.99
EPS(TTM)2.21
EY12.82%
EPS(NY)1.79
Fwd EY10.4%
FCF(TTM)2.07
FCFY12.01%
OCF(TTM)2.09
OCFY12.14%
SpS3.58
BVpS24.11
TBVpS24.1
PEG (NY)1.22
PEG (5Y)0.34
Profitability
Industry RankSector Rank
ROA 4.65%
ROE 9.19%
ROCE 7.04%
ROIC 4.52%
ROICexc 4.63%
ROICexgc 4.63%
OM 89.71%
PM (TTM) 61.91%
GM 73.12%
FCFM 57.84%
ROA(3y)2.69%
ROA(5y)1.6%
ROE(3y)5.18%
ROE(5y)3.03%
ROIC(3y)3.52%
ROIC(5y)3.08%
ROICexc(3y)3.79%
ROICexc(5y)3.29%
ROICexgc(3y)3.79%
ROICexgc(5y)3.29%
ROCE(3y)5.48%
ROCE(5y)4.8%
ROICexcg growth 3Y20.72%
ROICexcg growth 5Y9%
ROICexc growth 3Y20.74%
ROICexc growth 5Y9.01%
OM growth 3Y17.79%
OM growth 5Y7.19%
PM growth 3Y11.44%
PM growth 5Y20.21%
GM growth 3Y2.7%
GM growth 5Y-0.75%
F-Score5
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF 9.4
Debt/EBITDA 5.84
Cap/Depr 77.82%
Cap/Sales 0.6%
Interest Coverage 3.75
Cash Conversion 64.59%
Profit Quality 93.43%
Current Ratio 1.22
Quick Ratio 1.22
Altman-Z 0.97
F-Score5
WACC5.09%
ROIC/WACC0.89
Cap/Depr(3y)129.75%
Cap/Depr(5y)102.72%
Cap/Sales(3y)1.8%
Cap/Sales(5y)1.14%
Profit Quality(3y)3321.64%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15358.74%
EPS 3Y18.46%
EPS 5Y22.86%
EPS Q2Q%815.55%
EPS Next Y6.37%
EPS Next 2Y5.14%
EPS Next 3Y4.49%
EPS Next 5YN/A
Revenue 1Y (TTM)9.72%
Revenue growth 3Y5.68%
Revenue growth 5Y2.93%
Sales Q2Q%19.15%
Revenue Next Year11.76%
Revenue Next 2Y4.63%
Revenue Next 3Y3.14%
Revenue Next 5YN/A
EBIT growth 1Y57.69%
EBIT growth 3Y24.48%
EBIT growth 5Y10.33%
EBIT Next Year5.6%
EBIT Next 3Y5.28%
EBIT Next 5Y4.34%
FCF growth 1Y8.47%
FCF growth 3Y4.44%
FCF growth 5Y0.82%
OCF growth 1Y7.33%
OCF growth 3Y4.74%
OCF growth 5Y1.02%